Your browser doesn't support javascript.
loading
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
Schuettfort, Victor M; Pradere, Benjamin; D'Andrea, David; Grossmann, Nico C; Quhal, Fahad; Mostafaei, Hadi; Laukhtina, Ekaterina; Mori, Keiichiro; Rink, Michael; Karakiewicz, Pierre I; Motlagh, Reza Sari; Katayama, Satoshi; Lotan, Yair; Scherr, Douglas; Abufaraj, Mohammad; Fajkovica, Harun; Compérat, Eva; Enikeev, Dmitry; Shariat, Shahrokh F.
Afiliação
  • Schuettfort VM; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Pradere B; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Grossmann NC; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Mostafaei H; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
  • Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Mori K; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Rink M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Karakiewicz PI; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Motlagh RS; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Katayama S; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Lotan Y; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Scherr D; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Abufaraj M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fajkovica H; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada.
  • Compérat E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Enikeev D; Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
J Urol ; 206(5): 1122-1131, 2021 11.
Article em En | MEDLINE | ID: mdl-34181469
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Biomarcadores Tumorais / Cistectomia / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Biomarcadores Tumorais / Cistectomia / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria País de publicação: Estados Unidos